Last reviewed · How we verify

NCT00286039

Plasma Citrulline Level in Relation to Absorptive Surface

Completed NA Last updated 7 July 2021
What this trial tests

NA trial testing Blood sampling in Intestinal Failure in 200 participants. Completed in 1 September 2010.

Timeline
1 August 2005
Primary endpoint
1 September 2010
1 September 2010

Quick facts

Lead sponsorUniversity Hospital, Ghent
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment200
Start date1 August 2005
Primary completion1 September 2010
Estimated completion1 September 2010
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Ghent

Who can join

Under 18, any sex, with Intestinal Failure. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

Correlation between determination of citrulline in plasma or dried blood Reference ranges for healthy children and babies Longitudinal follow-up of citrulline in preterm babies

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Blood sampling

Trials testing the same drug.

Other recruiting trials for Intestinal Failure

Currently open trials in the same condition.

Other University Hospital, Ghent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00286039.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing